ATILA BIOSYSTEMS INC has a total of 14 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2016. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology and measurement are BECTON DICKINSON INFUSION THERAPY SYSTEMS INC, BEIJING ACCB BIOTECH LTD and SHANGHAI CHROMYSKY MEDICAL RES CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Microorganisms | |
#3 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Yang Zhijie | 12 |
#2 | Wang Youxiang | 12 |
#3 | Chen Xin | 12 |
#4 | Zhao Yu | 6 |
#5 | Wang Rong | 6 |
#6 | Alcivar James T | 2 |
#7 | Rogers Arthur H | 2 |
Publication | Filing date | Title |
---|---|---|
CN111183229A | Digital amplification using primers with limited nucleotide composition | |
CN109791108A | Device for the fluorescence signal that test sample issues | |
CN109477105A | Ω amplification | |
AU2016252998A1 | Amplification with primers of limited nucleotide composition |